Supply of Lenvatinib

This tender concerns the supply of Lenvatinib, a medication used in the treatment of certain types of cancer. The specific details regarding the quantity, dosage, and packaging requirements for Lenvatinib are expected to be outlined in the full tender documentation. Potential bidders are advised to carefully review all specifications to ensure compliance. The tender is likely to be issued by a healthcare procurement agency or a government health ministry responsible for acquiring essential medicines. The scope of work involves the procurement and delivery of Lenvatinib, ensuring it meets all relevant pharmaceutical quality standards and regulatory requirements. Interested parties should prepare to provide evidence of their ability to supply pharmaceutical products, including necessary licenses, certifications, and a proven track record in the supply chain management of oncology drugs. Further information regarding the submission deadline, evaluation criteria, and contract terms will be made available to registered bidders. This procurement aims to ensure the availability of this critical cancer treatment for patients within the designated healthcare system.

This is a services contract in the health and medical services, information and communication technology and general supplies sectors. Located in Chile, Latin America, this opportunity is open to firms and consortiums.

Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. This contract has already been awarded. The information is published for transparency and market intelligence purposes.